Roderick Spears, MD | |
1001 Chesterbrook Blvd, Berwyn, PA 19312-3805 | |
(610) 576-7600 | |
Not Available |
Full Name | Roderick Spears |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 1001 Chesterbrook Blvd, Berwyn, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336177096 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084N0400X | Psychiatry & Neurology - Neurology | MD442701 (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Roderick Spears, MD 1001 Chesterbrook Blvd, Berwyn, PA 19312-3805 Ph: (610) 576-7600 | Roderick Spears, MD 1001 Chesterbrook Blvd, Berwyn, PA 19312-3805 Ph: (610) 576-7600 |
News Archive
New guidelines from the Healthcare Infection Society (HIS) aimed at minimising surgical infection in day centres and primary care are now published in The Journal of Hospital Infection .
Merck Canada Inc. announced today that KEYTRUDATM (pembrolizumab) was authorized for sale with conditions by Health Canada on May 19, 2015. KEYTRUDA is a humanized monoclonal antibody that works by increasing the ability of the body's immune system to fight advanced melanoma, the most serious form of skin cancer. It is the first of a new class of therapies called anti-PD-1s approved in Canada.
Sutter Home Family Vineyards today announced the renewal of its annual Sutter Home for Hope program. Since 2001, Sutter Home has been committed to supporting breast cancer research through the consumer-driven Capsules for Hope program and has donated more than $800,000 toward breast cancer awareness.
A two-vaccine regimen intended to protect against Ebola virus disease induced an immune response that persisted for approximately one year in healthy adult volunteers, according to results from a Phase 1 clinical trial published in the March 14th issue of the Journal of the American Medical Association.
Researchers have developed a new imaging technique that makes it possible to study why proteins associated with Alzheimer's and Parkinson's diseases may go from harmless to toxic.
› Verified 3 days ago
Matthew Bloch, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1001 Chesterbrook Blvd Fl 3, Berwyn, PA 19312 Phone: 610-576-7600 Fax: 610-576-7705 | |
Dr. Lauren Wylonis, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1035 Sugartown Rd, Berwyn, PA 19312 Phone: 267-205-6741 | |
Lauren Cordes Flynn, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1001 Chesterbrook Blvd, 3rd Floor East, Berwyn, PA 19312 Phone: 610-576-7600 |